DUAL TRIGGERING OF FINAL OOCYTE MATURATION IN POOR OVARIAN RESPONDERS: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL.

被引：1
|
作者：
Khalife, Dalia [1 ]
Awwad, Johnny [1 ]
Ghunaim, Suleiman [1 ]
Abu-Musa, Antoine [1 ]
Beyrouthy, Christine [1 ]
Ghazeeri, Ghina Said [1 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Beirut, Lebanon
来源：
FERTILITY AND STERILITY | 2019年 / 112卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2019.07.207
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-68
引用
收藏
页码：E28 / E29
页数：2
相关论文
共 50 条
  • [21] Administration of FSH 8 hours post-triggering of final oocyte maturation with hCG does not improve oocyte maturation rate in normal responders undergoing ICSI
    Sfontouris, I.
    Lainas, G.
    Lainas, T.
    Venetis, C.
    Petsas, G.
    Zorzovilis, I.
    Tarlatzis, B.
    Kolibianakis, E.
    HUMAN REPRODUCTION, 2017, 32 : 471 - 471
  • [22] FOLLICULAR FLUSHING IN VERY POOR RESPONDERS: A RANDOMIZED CONTROLLED TRIAL
    Mok-Lin, E.
    Aelion-Brauer, A.
    Spandorfer, S.
    Rosenwaks, Z.
    FERTILITY AND STERILITY, 2012, 98 (03) : S57 - S57
  • [23] Is oocyte maturation rate associated with triptorelin dose used for triggering final oocyte maturation in patients at high risk for severe ovarian hyperstimulation syndrome?
    Lainas, G. T.
    Lainas, T. G.
    Sfontouris, I. A.
    Chatzimeletiou, K.
    Venetis, C. A.
    Bosdou, J. K.
    Tarlatzis, B. C.
    Grimbizis, G. F.
    Kolibianakis, E. M.
    HUMAN REPRODUCTION, 2019, 34 (09) : 1770 - 1777
  • [24] Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders
    Humaidan, P.
    Chin, W.
    Rogoff, D.
    D'Hooghe, T.
    Longobardi, S.
    Hubbard, J.
    Schertz, J.
    HUMAN REPRODUCTION, 2017, 32 (03) : 544 - 555
  • [25] Recombinant vs. urinary human chorionic gonadotrophin (hCG) for triggering final oocyte maturation in patients at risk for ovarian hyperstimulation syndrome OHSS: a randomized clinical trial
    Lainas, G.
    Lainas, T.
    Venetis, C.
    Sfontouris, I.
    Zorzovilis, I.
    Petsas, G.
    Bosdou, J.
    Tarlatzis, B.
    Kolibianakis, E.
    HUMAN REPRODUCTION, 2016, 31 : 452 - 453
  • [26] 450 IU vs. 600 IU of gonadotropins for controlled ovarian stimulation in poor responders: a randomized controlled trial
    Lefebvre, J.
    Antaki, R.
    Dean, N.
    Sylvestre, C.
    Bissonnette, F.
    Kadoch, I. J.
    Benoit, J.
    Menard, S.
    Monceau, E.
    Lapensee, L.
    HUMAN REPRODUCTION, 2014, 29 : 14 - 15
  • [27] GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?
    S. Kol
    I. Solt
    Journal of Assisted Reproduction and Genetics, 2008, 25 : 63 - 66
  • [28] GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?
    Kol, S.
    Solt, I.
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2008, 25 (2-3) : 63 - 66
  • [29] Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist
    Lu, Xuefeng
    Hong, Qingqing
    Sun, LiHua
    Chen, Qiuju
    Fu, Yonglun
    Ai, Ai
    Lyu, Qifeng
    Kuang, Yanping
    FERTILITY AND STERILITY, 2016, 106 (06) : 1356 - 1362
  • [30] Evidence of Impaired Endometrial Receptivity Following Controlled Ovarian Stimulation: a Prospective Randomized Trial in High Responders
    Shapiro, B. S.
    Daneshmand, S. T.
    Garner, F. C.
    Aguirre, M.
    Hudson, C.
    FERTILITY AND STERILITY, 2011, 95 (04) : S6 - S6
12345